2018 Transferred values declared to VVKT

Transferred values

2018 Disclosing Reports for transfered values

AbbVie, UAB

2019-06-06

Amgen Switzerland AG Vilniaus Filialas

2019-06-06

AstraZeneca Lietuva, UAB

2019-06-06

Bayer, UAB

2019-06-06

Berlin Chemie Menarini Baltic, UAB

2019-06-06

BGP Products, UAB / Mylan

2019-06-06

Boehringer Ingelheim RCV GmbH & Co KG Lietuvos filialas

2019-06-06

Celgene International S.a.r.l.

2019-06-06

Egis Pharmaceuticals PLC atstovybė Lietuvoje

2019-06-06

Eli Lilly Lietuva, UAB

2019-06-06

Gedeon Richter Plc. atstovybė Lietuvoje

2019-06-06

Glaxosmithkline Lietuva, UAB

2019-06-06

Grindeks, AB filialas

2019-06-06

IPSEN Pharma SAS Lietuvos filialas

2019-06-06

Johnson & Johnson, UAB

2019-06-06

Merck Serono, UAB

2019-06-06

Merck Sharp & Dohme, UAB

2019-06-06

Morfėjus, UAB

2019-06-06

Novartis Pharma Services Inc. atstovybė

2019-06-06

Novo Nordisk Pharma, UAB

2019-06-06

Pfizer Luxembourg SARL filialas

2019-06-06

Polpharma, farmacinės įmonės S. A. atstovybė

2019-06-06

Roche Lietuva, UAB

2019-06-06

Sandoz Pharmaceuticals d.d. filialas

2019-06-06

Sanofi-Aventis Lietuva, UAB

2019-06-06

Servier Pharma, UAB

2019-06-06

Shire

2019-06-06

Sicor Biotech, UAB / Teva Baltics ir Actavis

2019-06-06

Takeda, UAB

2019-06-06

Valentis Pharma, UAB

2019-06-06

ZENTIVA GROUP, a.s. Lietuvos filialas

2019-06-06

Companies that had no transferred values during year 2018

Accord Healthcare OU Lietuvos filialas

GL Pharma Vilnius, UAB

Disclosure reports of 2023 transfers of value

Disclosure reports of 2022 transfers of value

Disclosure reports of 2021 transfers of value

Disclosure reports of 2020 transfers of value

Disclosure reports of 2019 transfers of value

Disclosure reports of 2017 transfers of value

Disclosure reports of 2016 transfers of value

Disclosure reports of 2015 transfers of value